C07D209/40

5-bromo-indirubins

Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.

5-bromo-indirubins

Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.

COMPOUNDS AND METHODS FOR INHIBITING FASCIN
20210340138 · 2021-11-04 ·

Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.

COMPOUNDS AND METHODS FOR INHIBITING FASCIN
20210340138 · 2021-11-04 ·

Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.

CONDUCTING REACTIONS IN LEIDENFROST-LEVITATED DROPLETS
20220411373 · 2022-12-29 ·

The invention generally relates to conducting reactions in Leidenfrost-levitated droplets.

CONDUCTING REACTIONS IN LEIDENFROST-LEVITATED DROPLETS
20220411373 · 2022-12-29 ·

The invention generally relates to conducting reactions in Leidenfrost-levitated droplets.

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

5-BROMO-INDIRUBINS

Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.

5-BROMO-INDIRUBINS

Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.